Cargando…

Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers

The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Andrew C., Järhult, Josef D., Grabic, Roman, Khan, Ghazanfar A., Lindberg, Richard H., Fedorova, Ganna, Fick, Jerker, Bowes, Michael J., Olsen, Björn, Söderström, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177917/
https://www.ncbi.nlm.nih.gov/pubmed/25254643
http://dx.doi.org/10.1371/journal.pone.0108621
_version_ 1782336866303868928
author Singer, Andrew C.
Järhult, Josef D.
Grabic, Roman
Khan, Ghazanfar A.
Lindberg, Richard H.
Fedorova, Ganna
Fick, Jerker
Bowes, Michael J.
Olsen, Björn
Söderström, Hanna
author_facet Singer, Andrew C.
Järhult, Josef D.
Grabic, Roman
Khan, Ghazanfar A.
Lindberg, Richard H.
Fedorova, Ganna
Fick, Jerker
Bowes, Michael J.
Olsen, Björn
Söderström, Hanna
author_sort Singer, Andrew C.
collection PubMed
description The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir’s active metabolite, oseltamivir carboxylate (OC), were measured weekly at 21 locations within the River Thames catchment in England during the month of November 2009, the autumnal peak of the influenza A[H1N1]pdm09 pandemic. The aim was to quantify the pharmaceutical response to the pandemic and compare this to drug use during the late pandemic (March 2010) and the inter-pandemic periods (May 2011). A large and small wastewater treatment plant (WWTP) were sampled in November 2009 to understand the differential fate of the analytes in the two WWTPs prior to their entry in the receiving river and to estimate drug users using a wastewater epidemiology approach. Mean hourly OC concentrations in the small and large WWTP’s influent were 208 and 350 ng/L (max, 2070 and 550 ng/L, respectively). Erythromycin was the most concentrated antibiotic measured in Benson and Oxford WWTPs influent (max = 6,870 and 2,930 ng/L, respectively). Napthazoline and oxymetazoline were the most frequently detected and concentrated decongestant in the Benson WWTP influent (1650 and 67 ng/L) and effluent (696 and 307 ng/L), respectively, but were below detection in the Oxford WWTP. OC was found in 73% of November 2009’s weekly river samples (max = 193 ng/L), but only in 5% and 0% of the late- and inter-pandemic river samples, respectively. The mean river concentration of each antibiotic during the pandemic largely fell between 17–74 ng/L, with clarithromycin (max = 292 ng/L) and erythromycin (max = 448 ng/L) yielding the highest single measure. In general, the concentration and frequency of detecting antibiotics in the river increased during the pandemic. OC was uniquely well-suited for the wastewater epidemiology approach owing to its nature as a prodrug, recalcitrance and temporally- and spatially-resolved prescription statistics.
format Online
Article
Text
id pubmed-4177917
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41779172014-10-02 Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers Singer, Andrew C. Järhult, Josef D. Grabic, Roman Khan, Ghazanfar A. Lindberg, Richard H. Fedorova, Ganna Fick, Jerker Bowes, Michael J. Olsen, Björn Söderström, Hanna PLoS One Research Article The concentration of eleven antibiotics (trimethoprim, oxytetracycline, ciprofloxacin, azithromycin, cefotaxime, doxycycline, sulfamethoxazole, erythromycin, clarithromycin, ofloxacin, norfloxacin), three decongestants (naphazoline, oxymetazoline, xylometazoline) and the antiviral drug oseltamivir’s active metabolite, oseltamivir carboxylate (OC), were measured weekly at 21 locations within the River Thames catchment in England during the month of November 2009, the autumnal peak of the influenza A[H1N1]pdm09 pandemic. The aim was to quantify the pharmaceutical response to the pandemic and compare this to drug use during the late pandemic (March 2010) and the inter-pandemic periods (May 2011). A large and small wastewater treatment plant (WWTP) were sampled in November 2009 to understand the differential fate of the analytes in the two WWTPs prior to their entry in the receiving river and to estimate drug users using a wastewater epidemiology approach. Mean hourly OC concentrations in the small and large WWTP’s influent were 208 and 350 ng/L (max, 2070 and 550 ng/L, respectively). Erythromycin was the most concentrated antibiotic measured in Benson and Oxford WWTPs influent (max = 6,870 and 2,930 ng/L, respectively). Napthazoline and oxymetazoline were the most frequently detected and concentrated decongestant in the Benson WWTP influent (1650 and 67 ng/L) and effluent (696 and 307 ng/L), respectively, but were below detection in the Oxford WWTP. OC was found in 73% of November 2009’s weekly river samples (max = 193 ng/L), but only in 5% and 0% of the late- and inter-pandemic river samples, respectively. The mean river concentration of each antibiotic during the pandemic largely fell between 17–74 ng/L, with clarithromycin (max = 292 ng/L) and erythromycin (max = 448 ng/L) yielding the highest single measure. In general, the concentration and frequency of detecting antibiotics in the river increased during the pandemic. OC was uniquely well-suited for the wastewater epidemiology approach owing to its nature as a prodrug, recalcitrance and temporally- and spatially-resolved prescription statistics. Public Library of Science 2014-09-25 /pmc/articles/PMC4177917/ /pubmed/25254643 http://dx.doi.org/10.1371/journal.pone.0108621 Text en © 2014 Singer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Singer, Andrew C.
Järhult, Josef D.
Grabic, Roman
Khan, Ghazanfar A.
Lindberg, Richard H.
Fedorova, Ganna
Fick, Jerker
Bowes, Michael J.
Olsen, Björn
Söderström, Hanna
Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title_full Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title_fullStr Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title_full_unstemmed Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title_short Intra- and Inter-Pandemic Variations of Antiviral, Antibiotics and Decongestants in Wastewater Treatment Plants and Receiving Rivers
title_sort intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177917/
https://www.ncbi.nlm.nih.gov/pubmed/25254643
http://dx.doi.org/10.1371/journal.pone.0108621
work_keys_str_mv AT singerandrewc intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT jarhultjosefd intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT grabicroman intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT khanghazanfara intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT lindbergrichardh intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT fedorovaganna intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT fickjerker intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT bowesmichaelj intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT olsenbjorn intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers
AT soderstromhanna intraandinterpandemicvariationsofantiviralantibioticsanddecongestantsinwastewatertreatmentplantsandreceivingrivers